Evidence map›Paper›PMID 15899862›Full record

ArticleMolecular and cellular biology2005

Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes.

Mauricio J Reginato, Kenna R Mills, Esther B E Becker, Danielle K Lynch, Azad Bonni, Senthil K Muthuswamy, Joan S Brugge

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 138 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Dihydroceramide desaturase 1 (DES1) promotes anchorage-independent survival downstream of HER2-driven glucose uptake and metabolism.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  6. Review
  7. Oncogenic signaling inhibits c-FLIPScientific reports · 2021
    Article
  8. Tumor reversion: a dream or a reality.Biomarker research · 2021
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mauricio J ReginatoHarvard Medical School, Department of Cell Biology, 240 Longwood Ave., Boston, MA 02115, USA.
Kenna R Mills
Esther B E Becker
Danielle K Lynch
Azad Bonni
Senthil K Muthuswamy
Joan S Brugge
Harvard University · US

Funding

Cell Death Regulation in Lumen Formation and OncogenesisR01CA105134 · NCI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BRUGGE, JOAN SIEFERT · 2003 to 2012
$4.1M
NCI NIH HHS R01 CA105134
6 · The paper itself

Abstract

Epithelial cells organize into cyst-like structures that contain a spherical monolayer of cells that enclose a central lumen. Using a three-dimensional basement membrane culture model in which mammary epithelial cells form hollow, acinus-like structures, we previously demonstrated that lumen formation is achieved, in part, through apoptosis of centrally localized cells. We demonstrate that the proapoptotic protein Bim may selectively trigger apoptosis of the centrally localized acinar cells, leading to temporally controlled lumen formation. Bim is not detectable during early stages of three-dimensional mammary acinar morphogenesis and is then highly upregulated in all cells of acini, coincident with detection of apoptosis in the centrally localized acinar cells. Inhibition of Bim expression by RNA interference transiently blocks luminal apoptosis and delays lumen formation. Oncogenes that induce acinar luminal filling, such as ErbB2 and v-Src, suppress expression of Bim through a pathway dependent on Erk-mitogen-activated protein kinase; however, HPV 16 E7, an oncogene that stimulates cell proliferation but not luminal filling, is unable to reduce Bim expression. Thus, Bim is a critical regulator of luminal apoptosis during mammary acinar morphogenesis in vitro and may be an important target of oncogenes that disrupt glandular epithelial architecture.

Indexed as

ApoptosisAdaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsBcl-2-Like Protein 11bcl-X ProteinCarrier ProteinsCell Culture TechniquesCell DifferentiationCells, CulturedEpithelial CellsErb-b2 Receptor Tyrosine KinasesExtracellular Signal-Regulated MAP KinasesFemaleGenes, erbB-2Genes, srcHumansAdaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsBCL2L11 protein, humanBCL2L1 protein, humanBcl-2-Like Protein 11bcl-X ProteinCarrier ProteinsErb-b2 Receptor Tyrosine KinasesExtracellular Signal-Regulated MAP KinasesMembrane ProteinsOncogene Protein pp60(v-src)Proto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2

Identifiers

PMID15899862
PMCPMC1140636
OpenAlexW2063570387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.